20.07.2020 • News

Aramco Reorganizes Downstream Business

Saudi Aramco said it will reorganize its downstream business by the end of the year to support and enhance integration across the hydrocarbon value chain and better position the group to drive financial performance, value creation and global growth.

The reorganized operating model will include four commercial business units: Fuels (includes refining, trading, retail and lubes); Chemicals; Power; and Pipelines, Distribution & Terminals. The units will be supported by three corporate functions: manufacturing, strategy & marketing and affiliates affairs.

The oil giant added that the reorganization was not a fundamental change to its overall business structure.

On Jun. 17, Aramco completed the acquisition of a 70% stake in compatriot chemical producer SABIC. The shareholding, bought from Saudi Arabian sovereign wealth fund Public Investment Fund for $69.1 million, was part of crown prince Mohammed bin Salman’s drive to diversify the Kingdom’s economy away from oil.

For Aramco, the stake is part of a long-term downstream strategy to grow its integrated refining and petrochemicals capacity and leverage petrochemicals growth opportunities.

Saudi Aramco will reorganize its downstream operations into four business units...
Saudi Aramco will reorganize its downstream operations into four business units by the end of the year. The move will support and enhance integration across the hydrocarbon value chain and better position the group to drive financial performance, value creation and global growth. (c) Aramco

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.